HKU Scholars Hub: Browsing DSpace

Browsing by Author Feng, YH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 3 of 3

	Title	Author(s)	Issue Date
	Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens Journal:Breast Cancer Research and Treatment	Dai, MS Feng, YH Chen, SW Masuda, N Yau, T Chen, ST Lu, YS Yap, YS Ang, PCS Chu, SC Kwong, A Lee, KS Ow, S Kim, SB Lin, J Chung, HC Ngan, R Kok, VC Rau, KM Sangai, T Ng, TY Tseng, LM Bryce, R Bebchuk, J Chen, MC Hou, MF	2021
	Atezolizumab Plus Bevacizumab Versus Sorafenib in the Chinese Subpopulation With Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study Journal:Liver Cancer	Qin, S Ren, Z Feng, YH Yau, TCC Wang, B Zhao, H Bai, Y Gu, S Li, L Hernandez, S Xu, DZ Mulla, S Wang, Y Shuo, H Cheng, AL	2020
	Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial Journal:Journal of Clinical Oncology	Saura, C Oliveira, M Feng, YH Dai, MS Chen, SW Hurvitz, SA Kim, SB Moy, B Delaloge, S Gradishar, W Masuda, N Palacova, M Trudeau, ME Mattson, J Yap, YS V, MF De Laurentiis, M Yeh, YM Chang, HT Yau, T Wildiers, H Haley, B Fagnani, D Lu, YS Crown, J Lin, J Takahashi, M Takano, T Yamaguchi, M Fujii, T Yao, B Bebchuk, J Keyvanjah, K Bryce, R Brufsky, A The NALA Investigators	2020

Showing results 1 to 3 of 3